You are here

Bimzelx

UCB rapidly bolsters blockbuster potential for Bimzelx with 3 new FDA approvals

Fierce Pharma

Mon, 09/23/24 - 10:19 pm

psoriatic arthritis

radiographic axial spondyloarthritis

ankylosing spondylitis

Seeking blockbuster status, UCB eyes 4 new indications for psoriasis med Bimzelx in 2024

Fierce Pharma

Wed, 02/28/24 - 09:47 pm

UCB Wins FDA Approval for Plaque Psoriasis Therapy After Regulatory Setbacks

BioSpace

Thu, 10/19/23 - 10:15 am

Spotlight – following Humira in hidradenitis suppurativa

EP Vantage

Tue, 04/4/23 - 10:10 am

hidradenitis suppurativa

MoonLake Immunotherapeutics

AAD 2023 – UCB and Acelyrin take aim at hidradenitis suppurativa

EP Vantage

Tue, 03/21/23 - 09:54 am

hidradenitis suppurativa

Go or no go? UCB bids to make a mark in psoriasis

EP Vantage

Mon, 10/4/21 - 10:35 am